Who really benefits from drug combinations and long titrations for pain? – Authors' reply
We thank Thomas Perry for taking the time to read and respond to our work. In the OPTION-DM trial,1 we included pregabalin rather than gabapentin as pregabalin is a twice-daily drug that made blinded dosing easier for the trial, has 3–4 times faster absorption after oral administration, has dose-dependent predictable plasma concentration, and requires a shorter titration period.2,3 Moreover, there was little rationale in having two drugs with a similar mechanism of action. We disagree with the statement “evidence for dose response from analgesics is tenuous” as some analgesics, such as p...